Dr. Yanyan Lou, MD

Dr. Lou practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Lou's NPI, 1659505915, was assigned on May 14, 2009. Dr. Lou graduated from Zhengzhou University in 1997. Dr. Lou holds Florida license ME123592.

Dr. Lou's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Lou's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville. Dmand AI also links Dr. Lou to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lou practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Lou's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lou is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Lou's licenses on file in 2 states: Florida and Texas.

Dmand AI lists breast cancer, chronic leukemia, colorectal cancer, lung cancer, multiple myeloma and prostate cancer among the conditions Dr. Lou treats.

CMS data shows 93,388 Medicare services from Dr. Lou across 61 procedure codes in 2024, for 868 Medicare patients. Medicare paid $1,538,379 for them. Every service was in an office.

CMS counts 868 Medicare patients who saw Dr. Lou in 2024. The largest group is 65 to 74, with 438 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 2.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lou's median patient age at 64, with 54% women.

In 2024, Dr. Lou wrote 217 Medicare Part D claims for 47 patients. 55% of them were for generic drugs. CMS names the drug for 132 of them, across 6 drugs with 11 or more claims each, at $810,571 in total drug cost. In 2023, CMS named 78 claims across 4 drugs.

Dr. Lou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lou as offering telehealth.

Dmand AI links 110 papers to Dr. Lou, published from 2001 to 2025. 2021 was the busiest year, with 18. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Immunotherapy. Dr. Lou has published most often in Front Oncol. Dr. Lou's most frequent co-authors are Rami Manochakian, MD, Yujie Zhao, MD, PhD and Shenduo Li, MD, PhD.

Dmand AI links Dr. Lou to 11 clinical trials, 3 of them phase 1 studies. 6 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Carcinoma, Merkel Cell. Mayo Clinic sponsors the most, 4. Open Payments lists research payments to Dr. Lou that name 1 trial.

CMS Open Payments shows 79 general payments to Dr. Lou from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 81% of the total. AstraZeneca Pharmaceuticals LP paid the most, $28,774. It also lists 1 research payment totaling $1,620 in 2022, naming 1 clinical trial.

Dr. Lou graduated from Zhengzhou University in 1997. Dr. Lou is a member of ASCO.

Dr. Lou is in network with 9 carriers, including Excellus BlueCross BlueShield, Elevance and United Healthcare. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.